Datasheet
- Strength per vial
- 5 mg
- SKU
- TR5
- CAS number
- 2023788-19-2
- Formula
- C₂₂₅H₃₄₈N₄₈O₆₈
- Molecular weight
- 4813.5 g/mol
- Form
- Lyophilized powder
- Storage
- −20 °C long-term. Keep sealed, dry and away from light.
Incretins
Tirzepatide
Tirzepatide is a 39-amino-acid peptide that is an agonist at both the GIP and GLP-1 receptors.
$20.00 per vial
Ships ~Nov 22Ships around Sun, Nov 22. Delivery time after dispatch is additional.
Total for 1 vial: $20.00 before shipping and tax.
Save more on larger orders
- 3% off with 3+ vials
- 5% off with 6+ vials
- 8% off with 10+ vials
- Ships free when everything is in stock
- Pay with Bitcoin and save 20%
- Ships together, date shown before you pay
- Secure card payment through Stripe
- Each vial bubble-wrapped and padded
For laboratory research use only. Not for human or veterinary use.
Datasheet
- Strength per vial
- 5 mg
- SKU
- TR5
- CAS number
- 2023788-19-2
- Formula
- C₂₂₅H₃₄₈N₄₈O₆₈
- Molecular weight
- 4813.5 g/mol
- Form
- Lyophilized powder
- Storage
- −20 °C long-term. Keep sealed, dry and away from light.
Tirzepatide is a synthetic 39-amino-acid peptide based on the GIP sequence, carrying a C20 fatty-diacid side chain that binds albumin. It is an agonist at both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, and its signalling at each receptor has been characterised in cell-based assays.
- CAS number
- 2023788-19-2
- Molecular formula
- C₂₂₅H₃₄₈N₄₈O₆₈
- Molecular weight
- 4813.5 g/mol
- Form
- Lyophilized powder
- Storage
- −20 °C long-term. Keep sealed, dry and away from light.
- Single peptide that activates the GIP and GLP-1 receptors
- Fatty-diacid side chain binds albumin
- Signalling bias at the GLP-1 receptor has been described in cell-based assays
- 01Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight (2020)